A retrospective study for virologic patterns of HCV patients with failure to second-generation DAAs
Latest Information Update: 08 Apr 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Glecaprevir/pibrentasvir (Primary) ; Sofosbuvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary) ; Velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 08 Apr 2020 New trial record
- 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections